Sales of Johnson & Johnson's pharmaceutical products 2015-2019

Johnson and Johnson is a major international pharmaceutical company. In 2019, among its top pharmaceutical drugs was Remicade which earned 4.38 billion U.S. dollars in sales for the company. Remicade is a drug used in the treatment of Crohn’s disease and ulcerative colitis. The highest revenue generating drug at that time was Stelara which generated 6.36 billion U.S. dollars in revenue for the company.

International pharmaceutical companies

There are several major pharmaceutical companies that are making significant economic impacts globally. As of 2018, Pfizer, Roche and Novartis were the top pharmaceutical companies based on their prescription drug sales globally. Despite being excluded from the top three list of pharmaceutical companies based on prescription drug sales, Johnson and Johnson is among the top four drug companies based on drug sales. However, when viewed by market capitalization, Johnson and Johnson, Novartis and Roche were the top three global companies.

Top pharmaceuticals

The global pharmaceutical industry has never generated as much revenue as it has in recent years. Globally, oncologics, antidiabetics and respiratory drug classes are the top three based on total sales. However, there are some drugs that are more widely distributed and sold globally. As of 2018, Humira from AbbVie, Eliquis from BMS/Pfizer and Revlimid by Celgene were the top drugs based on sales worldwide.

Sales of Johnson & Johnson's top pharmaceutical products from 2015 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

February 2020



Survey time period

2015 to 2019

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Johnson & Johnson"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.